Title of article
In-hospital management and outcome in women with acute myocardial infarction (data from the AMI-Florence Registry)
Author/Authors
Carrabba، نويسنده , , Nazario and Santoro، نويسنده , , Giovanni M. and Balzi، نويسنده , , Daniela and Barchielli، نويسنده , , Alessandro and Marchionni، نويسنده , , Niccolٍ and Fabiani، نويسنده , , Plinio and Landini، نويسنده , , Cristina and Scarti، نويسنده , , Luca and Santoro، نويسنده , , Gennaro and Valente، نويسنده , , Serafina and Verdiani، نويسنده , , Valerio and Buiatti، نويسنده , , Eva، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
6
From page
1118
To page
1123
Abstract
Primary percutaneous coronary intervention proved to be superior to thrombolysis in reducing ST-segment elevation acute myocardial infarction (STEAMI) mortality. However, whether such benefit is similar in women and men remains unclear. The aim of the present analysis was to assess the independent effect of female gender on management and on early and 1-year mortality in Florence, Italy, where primary percutaneous coronary intervention is the preferred reperfusion strategy for STEAMI. The study included a cohort of 920 unselected patients with STEAMI (men = 627, women = 293) prospectively enrolled in the AMI-Florence, population-based registry over 12 months. Women were older (76 vs 68 years, p <0.001) and more frequently had Killip class >I heart failure than men. The median delay to hospital admission was marginally longer in women (160 vs 130 minutes, p = 0.09). Coronary reperfusion treatment was performed less often in women (49% vs 58%, p <0.013); primary percutaneous coronary intervention was perfomed more often in both genders (90% vs 91%) and with similar median door-to-balloon time (50 vs 45 minutes, p = 0.44). Both in-hospital (16% vs 8%, p <0.001) and 1-year mortality (25% vs 18%, p = 0.016) were higher in women. However, after adjusting for age and other baseline characteristics, reperfusion treatment (odds ratio 1.27, 95% confidence interval [CI] 0.78 to 2.08) and 1-year mortality (hazard ratio [HR] 0.91, 95% CI 0.67 to 1.24) were independent of female gender. Compared with conservative therapy, reperfusion treatment was associated with a similar reduction in 1-year mortality in women (HR 0.59, 95% CI 0.34 to 1.02) and men (HR 0.58, 95% CI 0.37 to 0.92). Our data suggest that older age and several age-related factors may largely account for the higher mortality of women after STEAMI. Even in the general population,improvement in prognosis associated with reperfusion treatment is independent of gender.
Journal title
American Journal of Cardiology
Serial Year
2004
Journal title
American Journal of Cardiology
Record number
1898306
Link To Document